{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "932.50",
    "chg": -16.35,
    "chgp": "-1.72%",
    "dir": -1,
    "prev_price": "948.85",
    "mcapval": "16,737.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE987B01026",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "8.82 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Natco Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-natco-pharma-technically-bullish-or-bearish-3745316",
        "imagepath": "",
        "date": "2025-12-04 08:23:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Trend</strong></p>\n<p>As of 03 December 2025, Natco Pharma's technical trend has transitioned from mildly bearish to sideways. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. Such sideways trends often precede significant price moves, making it crucial for investors to monitor further developments closely.</p>\n<p>The stock closed at ₹934.55, marginally up from the previous close of ₹933.45. Intraday price action ranged between ₹923.50 and ₹944.40, reflecting moderate volatility within a relatively narrow band. The 52-week price range remains wide, with a low of ₹660.05 and a high of ₹1,504.00, underscoring the stock's historical price swings.</p>\n<p><strong>Weekly Technical Indicators: Mildly Bullish Signals</..."
      },
      {
        "title": "Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-technical-momentum-shifts-to-sideways-mixed-indicator-signals-emerge-3745159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_technicaldot_3745159.png",
        "date": "2025-12-04 08:00:30",
        "description": "Natco Pharma has exhibited a notable shift in its technical momentum, transitioning from a mildly bearish stance to a more sideways trend. This change is underscored by a complex interplay of technical indicators across weekly and monthly timeframes, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Why is Natco Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-natco-pharma-fallingrising-3742413",
        "imagepath": "",
        "date": "2025-12-03 00:40:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Performance Outshines Benchmarks</strong></p>\n<p>Natco Pharma’s recent price action has been robust, with the stock gaining 11.92% over the past week and 13.80% in the last month, significantly outperforming the Sensex’s modest gains of 0.65% and 1.43% respectively during the same periods. This sharp short-term appreciation contrasts with the stock’s year-to-date and one-year returns, which remain deeply negative at -32.71% and -34.03% respectively, while the Sensex has delivered positive returns of 8.96% and 6.09% over those intervals.</p>\n<p>Such divergence suggests that investors are currently focusing on near-term catalysts or technical factors rather than the longer-term fundamental challenges the company faces.</p>\n<div class=\"promo-strategy-box\">\n<p><strong>Our current Stoc..."
      },
      {
        "title": "Natco Pharma Sees Robust Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-sees-robust-value-trading-and-institutional-interest-amid-positive-momentum-3741220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_most_active_equities_by_value_3741220.png",
        "date": "2025-12-02 10:00:07",
        "description": "Natco Pharma Ltd. has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, demonstrating notable market interest and liquidity. The stock’s recent trading session reflected a strong presence of institutional participation and significant order flow, positioning it as a key focus for investors amid a mixed market backdrop."
      },
      {
        "title": "Natco Pharma Sees High Value Trading Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-sees-robust-value-trading-and-institutional-interest-amid-sector-outperformance-3737842",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_most_active_equities_by_value_3737842.png",
        "date": "2025-12-01 10:00:08",
        "description": "Natco Pharma Ltd., a notable player in the Pharmaceuticals & Biotechnology sector, recorded significant trading activity on 1 December 2025, with its shares witnessing robust value turnover and outperforming its sector peers. The stock’s price movement and trading volumes reflect heightened market interest amid a backdrop of shifting investor participation and liquidity considerations."
      },
      {
        "title": "Natco Pharma’s Evaluation Revised Amid Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-17-nov-2025-3732979",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatcoPharma_mojoScore_3732979.png",
        "date": "2025-11-27 10:06:45",
        "description": "Natco Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of stable quality metrics, attractive valuation, flat financial trends, and mildly bearish technical indicators, set against a challenging market environment for the pharmaceutical sector."
      },
      {
        "title": "Natco Pharma Sees High-Value Trading Amidst Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-sees-high-value-trading-amid-mixed-market-sentiment-3733307",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatcoPharma_most_active_equities_by_value_3733307.png",
        "date": "2025-11-27 10:00:14",
        "description": "Natco Pharma Ltd. emerged as one of the most actively traded stocks by value on 27 Nov 2025, registering a total traded volume exceeding 15.8 lakh shares and a turnover surpassing ₹144 crore. Despite this significant market activity, the stock's price performance lagged behind its sector and benchmark indices, reflecting a complex trading environment for this small-cap pharmaceutical player."
      },
      {
        "title": "Natco Pharma Sees Robust Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-surges-on-high-value-trading-and-institutional-interest-3731436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatcoPharma_most_active_equities_by_value_3731436.png",
        "date": "2025-11-26 13:00:07",
        "description": "Natco Pharma Ltd. has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, registering significant market interest and outperforming its sector peers on 26 Nov 2025. The stock’s trading dynamics reflect a notable shift in investor engagement following a brief period of subdued performance."
      },
      {
        "title": "Natco Pharma Hits Intraday High with Strong 7.8% Surge in Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-hits-intraday-high-with-744-surge-on-26-nov-2025-3731410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NatcoPharma_priceRelatedfactors_3731410.png",
        "date": "2025-11-26 12:22:58",
        "description": "Natco Pharma recorded a robust intraday performance on 26 Nov 2025, touching a high of ₹899, reflecting a 7.8% rise during the trading session. This surge marked a notable rebound following three consecutive days of decline, with the stock outperforming its sector and broader market indices."
      }
    ],
    "total": 5578,
    "sid": "156274",
    "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Dec-2025",
      "details": "Appointment of Mr. Amit Parekh as Executive Vice President - Finance & Accounts w.e.f. 2nd December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "29-Nov-2025",
      "details": "Intimation of Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "21-Nov-2025",
      "details": "Conclusion of USFDA inspection at our Manali Chennai API unit",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 20 Nov 25",
          "dt": "2025-11-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Natco Pharma technically bullish or bearish?

2025-12-04 08:23:23

Overview of Current Technical Trend

As of 03 December 2025, Natco Pharma's technical trend has transitioned from mildly bearish to sideways. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. Such sideways trends often precede significant price moves, making it crucial for investors to monitor further developments closely.

The stock closed at ₹934.55, marginally up from the previous close of ₹933.45. Intraday price action ranged between ₹923.50 and ₹944.40, reflecting moderate volatility within a relatively narrow band. The 52-week price range remains wide, with a low of ₹660.05 and a high of ₹1,504.00, underscoring the stock's historical price swings.

Weekly Technical Indicators: Mildly Bullish SignalsRead More

Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:00:30

Natco Pharma has exhibited a notable shift in its technical momentum, transitioning from a mildly bearish stance to a more sideways trend. This change is underscored by a complex interplay of technical indicators across weekly and monthly timeframes, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company.

Read More

Why is Natco Pharma falling/rising?

2025-12-03 00:40:50

Short-Term Performance Outshines Benchmarks

Natco Pharma’s recent price action has been robust, with the stock gaining 11.92% over the past week and 13.80% in the last month, significantly outperforming the Sensex’s modest gains of 0.65% and 1.43% respectively during the same periods. This sharp short-term appreciation contrasts with the stock’s year-to-date and one-year returns, which remain deeply negative at -32.71% and -34.03% respectively, while the Sensex has delivered positive returns of 8.96% and 6.09% over those intervals.

Such divergence suggests that investors are currently focusing on near-term catalysts or technical factors rather than the longer-term fundamental challenges the company faces.

Our current Stoc...

Read More

Natco Pharma Sees Robust Trading Activity Amid Sector Outperformance

2025-12-02 10:00:07

Natco Pharma Ltd. has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, demonstrating notable market interest and liquidity. The stock’s recent trading session reflected a strong presence of institutional participation and significant order flow, positioning it as a key focus for investors amid a mixed market backdrop.

Read More

Natco Pharma Sees High Value Trading Amid Sector Outperformance

2025-12-01 10:00:08

Natco Pharma Ltd., a notable player in the Pharmaceuticals & Biotechnology sector, recorded significant trading activity on 1 December 2025, with its shares witnessing robust value turnover and outperforming its sector peers. The stock’s price movement and trading volumes reflect heightened market interest amid a backdrop of shifting investor participation and liquidity considerations.

Read More

Natco Pharma’s Evaluation Revised Amid Mixed Financial and Market Signals

2025-11-27 10:06:45

Natco Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of stable quality metrics, attractive valuation, flat financial trends, and mildly bearish technical indicators, set against a challenging market environment for the pharmaceutical sector.

Read More

Natco Pharma Sees High-Value Trading Amidst Sector Underperformance

2025-11-27 10:00:14

Natco Pharma Ltd. emerged as one of the most actively traded stocks by value on 27 Nov 2025, registering a total traded volume exceeding 15.8 lakh shares and a turnover surpassing ₹144 crore. Despite this significant market activity, the stock's price performance lagged behind its sector and benchmark indices, reflecting a complex trading environment for this small-cap pharmaceutical player.

Read More

Natco Pharma Sees Robust Trading Activity Amid Sector Outperformance

2025-11-26 13:00:07

Natco Pharma Ltd. has emerged as one of the most actively traded stocks by value in the Pharmaceuticals & Biotechnology sector, registering significant market interest and outperforming its sector peers on 26 Nov 2025. The stock’s trading dynamics reflect a notable shift in investor engagement following a brief period of subdued performance.

Read More

Natco Pharma Hits Intraday High with Strong 7.8% Surge in Trading

2025-11-26 12:22:58

Natco Pharma recorded a robust intraday performance on 26 Nov 2025, touching a high of ₹899, reflecting a 7.8% rise during the trading session. This surge marked a notable rebound following three consecutive days of decline, with the stock outperforming its sector and broader market indices.

Read More

View All News